Mabworks Biotech mab-works.com


Beijing Mabworks Biotech is a developer of gene engineering antibody medicines. Mabworks is currently developing antibody drugs, including an Ebola cure MIL77. Founded in 2003, Mabworks has two drugs in clinical trial: MIL60, a substitute of cancer and a specific eye disease drug Bevacizumab, and MIL62,a chronic lymphocytic leukemia drug.

Beijing Mabworks Biotech is a developer of gene engineering antibody medicines. Mabworks is currently developing antibody drugs, including an Ebola cure MIL77. Founded in 2003, Mabworks has two drugs in clinical trial: MIL60, a substitute of cancer a...Show all

Company (Alive / Active)

Phone: +86 010-59755429

Fax:

No. 99, Kechuang 14th Street
Economic-Technological Development Area
Beijing, 101111
China

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Mabworks Biotech $54M Jan 24, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Mabworks Biotech Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)